Show the Working

Repair UK-EU Trading Relationship

Liberal Democrat · what the evidence says

An independent, source-checked look at Liberal Democrat’s policy “Repair UK-EU Trading Relationship” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.

Public finances & the next generation — Helps

moderate · moderate confidence

By reducing trade barriers with the EU, this policy could raise UK productivity and GDP, which would boost tax revenues and improve the long-run sustainability of public finances. The main caveat is that the most ambitious element — rejoining the Single Market — depends on complex negotiations whose outcome is uncertain.

The evidence

Biggest unknown: Whether the EU will agree to an SPS deal, MRAs, and especially Single Market re-entry on terms the UK accepts, since the EU has stated the four freedoms are indivisible and cannot be cherry-picked.

Our reading: O12 is about debt-path sustainability and whether growth or borrowing finances public spending. This policy contains no direct spending commitments or tax changes, so its fiscal impact flows entirely through the GDP/productivity channel: higher economic output raises tax revenues, eases the debt-to-GDP ratio, and reduces pressure for borrowing to fund public services. The OBR's estimate of a 4% long-run productivity hit from Brexit is the key measurable baseline. A policy that partially reverses this — through SPS agreements reducing agri-food trade costs, MRAs eliminating costly dual-certification, and potentially Single Market re-entry — would mechanically improve the fiscal position by raising the tax base. Government analysis cited by the Resolution Foundation puts Single Market re-entry at +3.5% GDP relative to the TCA; even partial steps (SPS, MRAs) would capture a fraction of that. These are supply-side gains that compound over time, making the long-term time horizon appropriate. Critically, this policy does not involve unfunded spending or tax cuts — the standard routes to O12 harm. If anything, trade liberalisation is fiscally positive: it raises revenues without adding expenditure. The magnitude is moderate rather than major because (a) the most ambitious step — Single Market membership — faces a genuine negotiating obstacle (the EU's insistence on the four freedoms, including free movement, which conflicts with many UK parties' stated red lines), and (b) intermediate steps (SPS, MRAs) deliver real but smaller gains. The main uncertainty is whether negotiations succeed. If only SPS and MRA agreements are reached, the fiscal gain is real but modest. Full Single Market re-entry would be the larger prize but is politically and diplomatically contested. There is no credible mechanism by which this policy worsens O12 — it neither borrows nor cuts taxes unfundedly — so the direction is improves, with confidence moderated by negotiation uncertainty.

Prosperity & living standards — Helps

moderate · moderate confidence

Repairing the UK-EU trading relationship — through veterinary agreements, mutual recognition deals, and ultimately Single Market membership — is backed by strong institutional evidence that it would meaningfully raise productivity and living standards, though the biggest gains depend on steps (like Single Market entry) that face significant political obstacles. Near-term gains from an SPS or MRA deal would be real but smaller; the full uplift would take years to materialise.

The evidence

Biggest unknown: Whether the EU will agree to the most ambitious elements (SPS agreement, MRAs, Single Market access) on terms the UK will accept, given the EU's stated position that the four freedoms are indivisible and cannot be cherry-picked.

Our reading: The evidence base for this verdict is unusually strong and consistent in direction. The OBR's own modelling shows the current post-Brexit arrangement suppresses long-run UK productivity by 4% and trade volumes by ~15% — a large, evidence-grounded drag on living standards and business investment. Resolution Foundation data show a direct household living-cost hit of £870/year. These are the counterfactual baselines against which this policy's gains should be measured. The policy operates in three tiers of ambition, each with distinct near-term and long-term effects. First, an SPS/veterinary agreement would remove Export Health Certificates (up to £200/consignment), reduce border friction, and partially reverse the 37% decline in British farm product sales to the EU — real, measurable gains for agri-food businesses and supply chain efficiency. Second, MRAs would eliminate £127–171m/year in duplicate pharmaceutical testing and improve investment confidence in R&D-intensive sectors. Third, Single Market membership, if achieved, could recover roughly half of the 2–4% output loss since Brexit per Bloomberg Economics, and ~3.5% GDP relative to the TCA per government analysis. The direction is clearly 'improves' for O13: the policy targets the exact mechanisms that independent institutional analysis identifies as responsible for current productivity and investment losses. The near-term gains (SPS, MRAs) are modest but real; the long-term gains from deeper integration are substantial if achieved. Magnitude is 'moderate' rather than 'major' because the most economically significant step — Single Market membership — is highly uncertain. The EU's position that the four freedoms are indivisible creates a genuine negotiating obstacle, and the full productivity uplift would take years to materialise even if agreed. Near-term deliverables (SPS, MRAs) are meaningful but smaller in macro scale. One dissenting view (Lilley, E32) questions historical Single Market benefits for UK goods exports, but this is a single contrarian voice against OBR, Resolution Foundation, LSE, and Bloomberg — it cannot overturn the weight of institutional evidence.

Cost of living — Helps

moderate · moderate confidence

This policy aims to reduce trade barriers with the EU, which evidence suggests could lower food prices and business costs for ordinary households. The biggest uncertainty is whether the EU will agree to the terms sought, especially Single Market membership, which comes with significant political conditions.

The evidence

Biggest unknown: Whether the EU will negotiate the agreements on terms acceptable to the UK — especially Single Market access, which requires accepting free movement and EU rules.

Our reading: The evidence consistently shows that Brexit-era trade friction has raised costs for UK households — through higher food prices, export health certificate costs, and broader cost-of-living impacts estimated at £870 per household annually. An SPS/veterinary agreement, the first step in this policy, is projected to directly reduce these costs by eliminating export health certificates and border checks on agri-food products, easing food price inflation. Mutual recognition agreements would cut dual-testing costs (estimated £127–171m annually in pharmaceuticals alone), potentially feeding through to consumer prices over time. Single Market membership, the policy's ultimate goal, carries the largest projected economic benefit (OBR: 4% productivity gain; RF: 3.5% GDP boost), and broad institutional consensus supports its cost-of-living benefits via lower prices and higher real incomes. The policy therefore has a plausible and evidence-backed pathway to improving cost of living for ordinary households, particularly lower-income ones who spend proportionally more on food and essentials. The main caveats are: (1) the stepped nature of this policy means near-term gains are modest (SPS/MRAs), with the largest gains conditional on Single Market accession which is politically uncertain and requires accepting free movement; (2) the evidence on Single Market benefits, while broad in consensus, is contested by some analysts; (3) timelines for negotiation are long, so impacts are felt over the long run rather than immediately. On balance, the direction is 'improves' — the evidence leans clearly toward cost-of-living benefits — but magnitude is moderate rather than major because the full gains are conditional on the most politically contentious step (Single Market membership) being achieved.

Good work & fair pay — Helps

moderate · moderate confidence

Repairing UK-EU trade ties — especially through a veterinary agreement and mutual recognition deals — would reduce costs and open markets for farmers, agri-food workers, and export-facing industries, supporting jobs and pay. But the biggest gains depend on whether the EU agrees to terms, which is uncertain.

The evidence

Biggest unknown: Whether the EU will negotiate the agreements on terms acceptable to the UK, given its stated position that the 'four freedoms' are indivisible and the UK cannot cherry-pick benefits.

Our reading: The evidence paints a clear picture of significant post-Brexit damage to work and earnings in trade-exposed sectors. A 37% fall in farm exports to the EU and the exit of 20,000 small exporters represent direct job and income losses for workers in agri-food and related supply chains. Non-tariff barriers raised trade costs by roughly 11%, squeezing margins and wages in export industries. The policy's staged approach — SPS agreement first, then MRAs, then Single Market — would progressively address these harms. An SPS agreement would cut per-consignment costs of up to £200, remove routine border checks, and re-open markets for currently banned products, directly improving the viability and employment conditions of farming and food businesses. MRAs would eliminate £127–171 million in annual dual-testing costs in pharmaceuticals, supporting high-quality jobs in that sector. Single Market membership would be the largest gain — government analysis projects a 3.5% GDP boost — which would over time feed into employment and real wages broadly. The direction is therefore 'improves', and the magnitude is moderate rather than major because: (a) the stepwise nature means gains accumulate slowly; (b) the EU's stated position makes full Single Market access genuinely uncertain; and (c) some regulatory alignment costs (e.g. reduced pesticide flexibility) could marginally constrain certain agricultural practices. Confidence is moderate because the measurable baseline evidence is strong, but the projected gains depend on negotiating outcomes that are not guaranteed.